Page last updated: 2024-10-23

bumetanide and Invasiveness, Neoplasm

bumetanide has been researched along with Invasiveness, Neoplasm in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Among the most prevalent and deadly primary brain tumors, high-grade gliomas evade complete surgical resection by diffuse invasion into surrounding brain parenchyma."1.37With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume. ( Cuddapah, VA; Dy, TE; Haas, BR; Rohn, KJ; Sontheimer, H; Watkins, S, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haas, BR2
Sontheimer, H2
Cuddapah, VA1
Watkins, S1
Rohn, KJ1
Dy, TE1

Other Studies

2 other studies available for bumetanide and Invasiveness, Neoplasm

ArticleYear
Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.
    Cancer research, 2010, Jul-01, Volume: 70, Issue:13

    Topics: Animals; Brain Neoplasms; Bumetanide; Cell Line, Tumor; Cell Movement; Female; Gene Knockdown Techni

2010
With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume.
    American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:5

    Topics: Brain Neoplasms; Bumetanide; Cell Line, Tumor; Cell Size; Glioma; Humans; Intracellular Signaling Pe

2011